Lasry Marc Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
+$572K |
| 2 |
XELAP
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
|
+$527K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DO
Diamond Offshore Drilling, Inc.
DO
|
+$89.4M |
| 2 |
Vistra
VST
|
+$29.3M |
| 3 |
Gulfport Energy Corp
GPOR
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 25.49% |
| 2 | Real Estate | 13.07% |
| 3 | Communication Services | 12.8% |
| 4 | Healthcare | 6.78% |
| 5 | Financials | 3.78% |
Similar funds
Lasry Marc's Q2 2022 Portfolio in Review
As of Q2 2022, Lasry Marc held 16 positions worth $65.7M, down 67% from $201M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Lasry Marc withdrew a net $127M in Q2 2022, closing 5 positions. Its most notable exit was Diamond Offshore Drilling, Inc., an estimated $89.4M position sold in full.
By sector, the portfolio is most concentrated in Energy at 25% of assets, down from 53% a quarter earlier, followed by Real Estate and Communication Services.
Against the trend, Lasry Marc opened a new position in Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock worth $542K.
- Lasry Marc's largest Q2 2022 buy was Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock: 77,498 shares worth $542K.
- Lasry Marc added most to Impel Pharmaceuticals Inc. Common Stock in Q2 2022, an estimated $572K increase.
- Lasry Marc fully exited Diamond Offshore Drilling, Inc. in Q2 2022, selling an estimated $89.4M.
- Lasry Marc's ten largest holdings make up 99% of its $65.7M portfolio in Q2 2022.
- Lasry Marc opened 2 new positions and closed 5 in Q2 2022.
- Lasry Marc's portfolio value fell 67% quarter-over-quarter to $65.7M.
Based on Lasry Marc's 13F filing for Q2 2022, filed 15 Aug 2022.